Cost-Effective Oxygen Therapy

Editorials1 September 1980Cost-Effective Oxygen TherapySTEPHEN D. ROBERTS, PH.D.STEPHEN D. ROBERTS, PH.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-93-3-499 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptWhen the outcome of a clinical trial shows that one treatment increases survival over alternative therapies, the result may be expected to establish a new standard of medical practice, particularly if the trial involves multiple clinical sites with a large number of patients and is conducted by a prominent group of investigators. The trial of continuous versus nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease, reported in this issue (1), may set such a standard of care. The study concludes that patients with hypoxemic chronic obstructive lung disease, particularly those with more severe derangements of lung and brain function...References1. . Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1080;93:391-8. Google Scholar2. LENFANT C. Twelve- or 24-hour oxygen therapy: why a clinical trial? JAMA. 1980;243:551-2. Editorial. CrossrefMedlineGoogle Scholar3. Facts about Selected Respiratory Conditions in the U.S. New York: American Lung Association; 1978. Publication AL-63. Google Scholar4. ROBERTSMAXWELLGROSS SDT. Cost-effective care of end-stage renal disease: a billion dollar question. Ann Intern Med. 1980;92:243-8. LinkGoogle Scholar5. STASONWEINSTEN WM. Allocation of resources to manage hypertension. N Engl J Med. 1977;296:732-9. CrossrefMedlineGoogle Scholar6. . Health United States 1979. Washington, D.C.: U. S. Government Printing Office; 1980. DHEW Publication No. (PHS)80-1232. Google Scholar7. COX D. Regression models and life tables. Stat Soc. 1972 (Series B);35:187-220. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Department of Medicine Regenstrief Institute for Health Care Indiana University School of Medicine Indianapolis, Indiana PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThe Role of Psychosocial Factors in Chronic Obstructive Pulmonary DiseaseA Program for Transtracheal Oxygen Delivery Assessment of Safety and EfficacyKENT L. CHRISTOPHER, M.D., BRYAN T. SPOFFORD, M.D., MARK D. PETRUN, M.D., DAWN C. McCARTY, R.R.T., JOHN P. GOODMAN, R.R.T., THOMAS L. PETTY, M.D.Home Oxygen TherapyOxigenoterapia continua domiciliaria. Estudio de 344 pacientesDomiciliary oxygen: the cost‐benefit dilemmaCardiopulmonary Effects of a Single Oral Dose of Almitrine at Rest and on Exercise in Patients with Hypoxic Chronic Airflow ObstructionA Demand Valve Conserves Oxygen in Subjects with Chronic Obstructive Pulmonary DiseaseThe Respiratory SystemCost-Benefit/Effectiveness AnalysesCost-Benefit Issues in U. S. National Health Legislation: The Case of the End-Stage Renal Disease ProgramHome Oxygen in Advanced Chronic Obstructive Pulmonary DiseaseHome oxygen therapy for COPDContinuous Versus Nocturnal Oxygen TherapyW. W. ARKINSTALL, M.D. 1 September 1980Volume 93, Issue 3Page: 499-500KeywordsBrainBrain diseasesClinical trialsLungsOxygen Issue Published: 1 September 1980 PDF DownloadLoading ...